Report Code : CVMI2312251 | Published Date : March 3, 2025

Market Overview

Cervical cancer screening is a preventive measure designed to detect early signs of precancerous changes or cervical cancer in asymptomatic women. Techniques such as Pap smear tests, HPV DNA testing, and visual inspection with acetic acid (VIA) are widely used. Increasing awareness, national screening programs, WHO elimination targets, and the integration of molecular diagnostics significantly enhance the global cervical cancer screening market.

 

Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2019

6.74

Includes test kits, diagnostics platforms, and service-based screenings

2024

10.12

CAGR 8.5% (2019–2024) with expanded HPV testing and AI cytology systems

2031

16.84

CAGR 7.5% (2024–2031); driven by LMIC screening rollout and vaccination synergy

The integration of AI-based cytology, point-of-care HPV diagnostics, and global vaccination programs will play a pivotal role in scaling coverage to eliminate cervical cancer.

 

Market Drivers

  • WHO’s Global Strategy for Cervical Cancer Elimination – Aims for 70% screening coverage by 2030
  • Shift from Pap to HPV DNA testing – Increased sensitivity and extended screening intervals
  • Public health campaigns and NGO funding: Enhancing access in low-resource settings
  • Rise in AI-based cytology analysis – Automating slide review and reducing human error
  • Home-based/self-sampling kits – Improving participation and reach in underserved populations

 

Market Challenges

  • Access disparities – Screening coverage remains <30% in many LMICs
  • Infrastructure gaps – Limited labs and cold-chain systems restrict adoption in rural areas
  • Cultural resistance – Social stigma and fear prevent test uptake
  • Reimbursement complexity – Inconsistent insurance support for newer HPV platforms
  • Diagnostic errors – False negatives and improper sample collection reduce reliability

 

Competitive Landscape

Company

2024 Share

Core Strengths

Recent Moves

Roche Diagnostics

24%

Cobas HPV DNA platform, CINtec Plus

Expanded cervical screening labs in Africa (2024)

Hologic

21%

ThinPrep Pap, Aptima HPV assays

Launched AI-supported Genius Digital Diagnostics (Q1 2025)

Qiagen

14%

digene HC2 HPV test, NeuMoDx systems

Partnership with FIND for LMIC access (Q2 2024)

BD (Becton Dickinson)

12%

SurePath Pap test, Onclarity HPV

Added self-collection kit support (Q3 2024)

Others (Seegene, Thermo Fisher, Abbott)

29%

Molecular diagnostics, rapid HPV kits

R&D in multiplexed HPV-STI testing

 

Market Segmentation
By Test Type:

  • Pap Smear Test – 36%
  • HPV DNA Test – 42%
  • VIA/Other Tests – XX%

 

By End User:

  • Hospitals & Diagnostic Labs – 58%
  • Home-Based/Outreach Services – XX%
  • Public Health Programs – XX%

 

Regional Analysis

  • North America – High awareness; HPV co-testing standard in US
  • Europe – Organized programs in Nordics and UK; increasing use of AI
  • Asia-Pacific – Rapid growth in India, China, Philippines with WHO funding
  • Latin America & MEA – Brazil and Kenya launching HPV DNA pilots under GAVI/UNFPA support

 

Recent Developments

  • Hologic launched AI-enhanced Pap screening platform in the EU (Q1 2025)
  • Roche introduced dual-stain CINtec markers in Southeast Asia (Q4 2024)
  • Qiagen began HPV testing kits supply through FIND in Sub-Saharan Africa (Q2 2024)

 

Strategic Outlook
Governments and payers must scale nationwide HPV DNA testing while supporting AI cytology and mobile screening units. Partnerships with NGOs and public-private models will be key to achieving WHO elimination targets.

Methodology
Clearview Market Insights conducted 96 interviews with oncologists, OB-GYNs, lab directors, and HPV researchers. Data modeling leveraged procurement data, lab volumes, and public health program funding across 28 countries.





Reasons To Buy

Image



Scope

Image
  • Hologic, Inc.
  • F. Hoffmann-La Roche Ltd
  • Qiagen N.V.
  • Becton, Dickinson and Company (BD)
  • Quest Diagnostics Incorporated
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Seegene Inc.
  • bioMérieux SA
  • Siemens Healthineers
  • Arbor Vita Corporation
  • Bio-Rad Laboratories, Inc.
  • OncoHealth Corporation
  • Cardinal Health, Inc.
  • Trinity Biotech plc

 

Cervical Cancer Screening Market Report


  1. 1. Cervical Cancer Screening Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Cervical Cancer Screening Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Cervical Cancer Screening Market Research Report - Preface
    1. 2.1 Cervical Cancer Screening Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Test Type
      2. 2.1.2 By End User
      3. 2.1.3 By Region
  3. 3. Cervical Cancer Screening Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Test Type, By End User, By Country
    3. 3.3. Opportunities – By Test Type, By End User, By Country
    4. 3.4. Trends – By Test Type, By End User, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Cervical Cancer Screening Market Research Report – DROTs Impact Analysis
    1. 4. Cervical Cancer Screening Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Cervical Cancer Screening Market, By Test Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Pap Smear Test
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 HPV DNA Test
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 VIA/Other Tests
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Cervical Cancer Screening Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Hospitals & Diagnostic Labs
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Home-Based/Outreach Services
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Public Health Programs
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 7. Cervical Cancer Screening Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 North America
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.2 Europe
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.3 Asia-Pacific
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.4 Latin America
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.5 Middle East and Africa
      1. 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.6 Cervical Cancer Screening Market - Opportunity Analysis Index, By Test Type, By End User, and Region, 2024 - 2031
  1. 8. North America Cervical Cancer Screening Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.1.1 Pap Smear Test
      2. 8.1.2 HPV DNA Test
      3. 8.1.3 VIA/Other Tests
      8.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.2.1 Hospitals & Diagnostic Labs
      2. 8.2.2 Home-Based/Outreach Services
      3. 8.2.3 Public Health Programs
      8.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.3.1 United States
      2. 8.3.2 Canada
    2. 8.4 North America Cervical Cancer Screening Market – Opportunity Analysis Index, By Test Type, By End User, and Country, 2024 - 2031
    3. 8.5 Regional Trends Analysis
    4. 8.6 North America Cervical Cancer Screening Market Research Report - Company Profiles
      1. 8.6.1 Company 1 (United States)
      2. 8.6.2 Company 2 (Canada)
      3. 8.6.3 Company 3 (Canada)
    9. Europe Cervical Cancer Screening Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Pap Smear Test
      2. 9.1.2 HPV DNA Test
      3. 9.1.3 VIA/Other Tests
      9.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Hospitals & Diagnostic Labs
      2. 9.2.2 Home-Based/Outreach Services
      3. 9.2.3 Public Health Programs
      9.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Germany
      2. 9.3.2 United Kingdom
      3. 9.3.3 France
      4. 9.3.4 Spain
      5. 9.3.5 Italy
      6. 9.3.6 Russia
      7. 9.3.7 Netherlands and Rest of Europe
    2. 9.4 Europe Cervical Cancer Screening Market – Opportunity Analysis Index, By Test Type, By End User, and Country, 2024 - 2031
    3. 9.5 Regional Trends Analysis
    4. 9.6 Europe Cervical Cancer Screening Market Research Report - Company Profiles
      1. 9.6.1 Company 1 (Germany)
      2. 9.6.2 Company 2 (United Kingdom)
      3. 9.6.3 Company 3 (United Kingdom)
    10. Asia-Pacific Cervical Cancer Screening Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Pap Smear Test
      2. 10.1.2 HPV DNA Test
      3. 10.1.3 VIA/Other Tests
      10.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Hospitals & Diagnostic Labs
      2. 10.2.2 Home-Based/Outreach Services
      3. 10.2.3 Public Health Programs
      10.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 China
      2. 10.3.2 Japan
      3. 10.3.3 India
      4. 10.3.4 South Korea
      5. 10.3.5 Australia & New Zealand
      6. 10.3.6 ASEAN
      7. 10.3.7 Rest of Asia-Pacific
    2. 10.4 Asia-Pacific Cervical Cancer Screening Market – Opportunity Analysis Index, By Test Type, By End User, and Country, 2024 - 2031
    3. 10.5 Regional Trends Analysis
    4. 10.6 Asia-Pacific Cervical Cancer Screening Market Research Report - Company Profiles
      1. 10.6.1 Company 1 (China)
      2. 10.6.2 Company 2 (Japan)
      3. 10.6.3 Company 3 (Japan)
    11. Latin America Cervical Cancer Screening Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Pap Smear Test
      2. 11.1.2 HPV DNA Test
      3. 11.1.3 VIA/Other Tests
      11.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Hospitals & Diagnostic Labs
      2. 11.2.2 Home-Based/Outreach Services
      3. 11.2.3 Public Health Programs
      11.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Brazil
      2. 11.3.2 Mexico
      3. 11.3.3 Argentina
      4. 11.3.4 Peru
      5. 11.3.5 Colombia
      6. 11.3.6 Rest of Latin America
    2. 11.4 Latin America Cervical Cancer Screening Market – Opportunity Analysis Index, By Test Type, By End User, and Country, 2024 - 2031
    3. 11.5 Regional Trends Analysis
    4. 11.6 Latin America Cervical Cancer Screening Market Research Report - Company Profiles
      1. 11.6.1 Company 1 (Brazil)
      2. 11.6.2 Company 2 (Mexico)
      3. 11.6.3 Company 3 (Mexico)
    12. Middle East and Africa Cervical Cancer Screening Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Pap Smear Test
      2. 12.1.2 HPV DNA Test
      3. 12.1.3 VIA/Other Tests
      12.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Hospitals & Diagnostic Labs
      2. 12.2.2 Home-Based/Outreach Services
      3. 12.2.3 Public Health Programs
      12.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Saudi Arabia
      2. 12.3.2 UAE
      3. 12.3.3 Qatar
      4. 12.3.4 Egypt
      5. 12.3.5 Israel
      6. 12.3.6 Rest of Middle East and Africa
    2. 12.4 Middle East and Africa Cervical Cancer Screening Market – Opportunity Analysis Index, By Test Type, By End User, and Country, 2024 - 2031
    3. 12.5 Regional Trends Analysis
    4. 12.6 Middle East and Africa Cervical Cancer Screening Market Research Report - Company Profiles
      1. 12.6.1 Company 1 (Saudi Arabia)
      2. 12.6.2 Company 2 (UAE)
      3. 12.6.3 Company 3 (UAE)
    13. Competition Landscape
    1. 13.1 Strategic Dashboard of Top Market Players
    2. 13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 13.2.1 Hologic Inc.
      2. 13.2.2 F. Hoffmann-La Roche Ltd
      3. 13.2.3 Qiagen N.V.
      4. 13.2.4 Becton
      5. 13.2.5 Dickinson and Company (BD)
      6. 13.2.6 Quest Diagnostics Incorporated
      7. 13.2.7 Abbott Laboratories
      8. 13.2.8 Thermo Fisher Scientific Inc.
      9. 13.2.9 Seegene Inc.
      10. 13.2.10 bioMérieux SA
      11. 13.2.11 Siemens Healthineers
      12. 13.2.12 Arbor Vita Corporation
      13. 13.2.13 Bio-Rad Laboratories Inc.
      14. 13.2.14 OncoHealth Corporation
      15. 13.2.15 Cardinal Health Inc.
      16. 13.2.16 Trinity Biotech plc
  1. 14. Data Collection Method and Research Approach
  2. 15. Principal Presumptions and Acronyms